CVS Denies Aetna Deal Reverses Efforts To Cut Drug Prices
CVS has told a D.C. federal judge that the drugstore chain's $69 billion megadeal with Aetna won't interfere with its pharmacy benefit manager's push to cut drug prices, despite what groups...To view the full article, register now.
Already a subscriber? Click here to view full article